Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
May 13, 2026
Why Is Red Cat Holdings (RCAT) Stock Down -13% Today?

Why Is Red Cat Holdings (RCAT) Stock Down -13% Today?

Key Takeaways

  • RCAT shares are falling approximately 13% in premarket trading on May 13, 2026, following the announcement of a $200 million stock offering that threatens significant shareholder dilution
  • The equity offering is the primary catalyst, unveiled before the market open and immediately pressuring the stock
  • A recent Q1 2026 earnings report (released May 7) added an overhang: revenue of $15.5 million missed the FactSet consensus estimate of $17.6 million, and EPS of -$0.22 badly missed the -$0.12 estimate
  • Despite record 849% year-over-year revenue growth driven by U.S. Army drone contracts, profitability and margin concerns remain front and center for investors
  • Shares had already closed Tuesday at $11.03, down nearly 2% on the day, suggesting the stock was under pressure even before the offering news broke
  • Traders are watching the size and pricing of the offering, any use-of-proceeds disclosures, and whether institutional demand is sufficient to absorb the new shares

Opening Summary

Red Cat Holdings (RCAT) is a Puerto Rico-based aerospace and defense company that designs and manufactures tactical drone systems — including its flagship Black Widow small unmanned aerial system (sUAS) — for the U.S. military, NATO allies, and government security agencies. Shares are tumbling roughly 13% in premarket trading on May 13, 2026, declining from Tuesday's closing price of $11.03 to approximately $9.60. The selloff is driven by the company's announcement of a $200 million stock offering, a capital raise that markets are pricing as a dilutive event for existing shareholders at a time when the stock's recent earnings report had already disappointed expectations.

$200 Million Stock Offering Triggers Dilution Selloff

The dominant catalyst for the sharp premarket decline is Red Cat's announcement of a $200 million equity offering, disclosed before Wednesday's opening bell. Stock offerings of this scale are routinely met with selling pressure because they increase the total share count outstanding, diluting the ownership percentage and earnings per share attributable to current investors. The size of the raise is especially notable given the company's current market capitalization, making the dilution particularly pronounced relative to its existing equity base. Investors are reacting by selling ahead of the pricing of the deal, a classic pattern in secondary offerings from smaller-cap growth companies in the defense technology space.

Earnings Miss Adds to the Bearish Backdrop

The offering announcement lands against an already uncertain earnings backdrop. On May 7, 2026, Red Cat reported Q1 fiscal 2026 results that showed $15.5 million in revenue — a record quarter and an extraordinary 849% jump year-over-year, fueled by scaled deliveries under the U.S. Army Short Range Reconnaissance (SRR) program — but still fell short of the FactSet consensus estimate of $17.6 million. The EPS miss was even more severe: the company posted a loss of $0.22 per share, compared to analyst expectations of a $0.10 loss, as operating expenses surged 152% to $29.3 million, driven by sharp increases in R&D, sales and marketing, and G&A costs. Free cash outflow of $31.9 million and a cash balance declining from $167.9 million to $131.9 million during the quarter also flagged burn rate concerns heading into the offering announcement.

Sector Momentum and Contract Win Context

Red Cat has been building an impressive contract portfolio. The company recently won a deal to deliver 173 Black Widow drone systems to Japan's Ministry of Defense, secured new orders from a NATO ally facilitated through the NATO Support and Procurement Agency, and completed the acquisition of swarm robotics firm Apium. These developments speak to strong demand for its defense drone platforms and alignment with the broader global defense spending supercycle. The drone sector has been a market darling on the back of escalating geopolitical tensions and increased government procurement budgets, with defense-focused peers posting outsized gains. However, the stock's ongoing net losses — net loss widened to $26.6 million in Q1 — and the now-confirmed capital raise suggest the growth is coming at a steep cost that the market is increasingly scrutinizing.

Market Context and Trading Activity

Premarket volume in RCAT has already surged significantly relative to its 30-day average premarket volume of approximately 394,000 shares, with over 379,000 shares having changed hands in early premarket hours — an elevated figure consistent with a major corporate event. The stock closed Tuesday at $11.03, itself off 1.96% from the prior session, indicating that selling pressure was building even before the offering news went public. The broader defense ETF space, including names like ITA, will be worth watching during the regular session to assess whether RCAT's move reflects company-specific concerns or a wider sector-level de-risking. The stock's year-to-date gain of approximately 39% heading into Wednesday's session means longer-term holders are still sitting on meaningful profits, which may accelerate selling as they lock in gains into the dilutive offering.

Trending AI Robots

For traders navigating high-volatility events like secondary offerings or earnings reactions in stocks such as RCAT, Tickeron's Trending AI Robots page offers a curated look at the platform's top-performing automated trading bots under current market conditions. Tickeron operates hundreds of AI-driven bots covering thousands of tickers across multiple asset classes, timeframes, and strategies — but only the strongest performers based on current market dynamics are featured in this dedicated Trending section. Each bot is characterized by its traded symbols, risk profile, holding period, and transparent performance metrics, giving traders a clear basis for comparison. Whether you are managing short-term swing trades or seeking systematic exposure to defense and technology trends, exploring the Trending AI Robots page is a sound starting point for integrating data-driven automation into your strategy.

What Comes Next for RCAT

The immediate priority for investors will be the final pricing and terms of the $200 million offering, including the disclosed use of proceeds — whether it targets acquisitions, working capital, SRR program scale-up, or further M&A in the drone ecosystem. Red Cat's next quarterly earnings report is expected around August 24, 2026, where analysts will be watching whether revenue growth is accelerating toward the upper end of contract delivery schedules and whether operating leverage begins to materialize. Contract execution risk remains high: the SRR program has been the engine of growth, and any delivery delays — as seen in prior quarters — could reset investor expectations sharply. Analyst consensus remains constructive, with an average price target of $21.75 from four analysts, though that target will almost certainly be revised following the dilutive offering. Key risks include ongoing net losses, geopolitical disruptions to NATO procurement timelines, integration execution for recently acquired Apium, and competitive pressure from larger defense primes entering the tactical drone market.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: RCAT

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


RCAT's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for RCAT turned positive on July 31, 2026. Looking at past instances where RCAT's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 03, 2026. You may want to consider a long position or call options on RCAT as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

RCAT moved above its 50-day moving average on August 10, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for RCAT crossed bullishly above the 50-day moving average on August 17, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where RCAT advanced for three days, in of 263 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for RCAT moved out of overbought territory on August 17, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 47 cases where RCAT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCAT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RCAT broke above its upper Bollinger Band on August 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for RCAT entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.118) is normal, around the industry mean (7.037). P/E Ratio (0.000) is within average values for comparable stocks, (60.208). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.077). Dividend Yield (0.000) settles around the average of (0.017) among similar stocks. P/S Ratio (16.026) is also within normal values, averaging (20.174).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RCAT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 40.4B. The market cap for tickers in the group ranges from 4.49 to 1.81T. SPCX holds the highest valuation in this group at 1.81T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -8%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was -3%. NPK experienced the highest price growth at 7%, while DFSC experienced the biggest fall at -48%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was -31%. For the same stocks of the Industry, the average monthly volume growth was -5% and the average quarterly volume growth was -7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 68
Price Growth Rating: 55
SMR Rating: 78
Profit Risk Rating: 73
Seasonality Score: -30 (-100 ... +100)
View a ticker or compare two or three
RCAT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry AerospaceDefense

Profile
Details
Industry
N/A
Address
2800 South West Temple
Phone
+1 800 466-9152
Employees
244
Web
https://www.redcat.red
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.